Home/Filings/4/0001562180-21-001774
4//SEC Filing

Cotreau Violetta 4

Accession 0001562180-21-001774

CIK 0001517022other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:06 PM ET

Size

7.5 KB

Accession

0001562180-21-001774

Insider Transaction Report

Form 4
Period: 2021-02-26
Cotreau Violetta
SVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2021-02-26+26,00038,900 total
  • Award

    Employee Stock Option (Right to buy)

    2021-02-26+44,20044,200 total
    Exercise: $3.46Exp: 2031-02-26Common Stock (44,200 underlying)
Footnotes (2)
  • [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
  • [F2]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1
  • filerCIK 0001841934

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:06 PM ET
Size
7.5 KB